2 publications
-
Published Subscription
A Brief Review on Novel (COVID-19) Corona Virus and Its Management – The Global Pandemic SituationBy Dr.SUSHMA MUCHUKOTA, Babu Muchukota, E. Bhavya, Vivekanandan K., Manjoor Ahamad Syed
Abstract: AbstractCOVID -19 is a respiratory disease that is contagious, first detected in china and worldwide spread in December 2019. The novel (new) coronavirus (nCoV) coronavirus disease 2019, or COVID-19 that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome(SARS-CoV). A novel coronavirus is a new strain that has not been previously identified in humans. Genus Coronaviruses …
Published in Research & Reviews: A Journal of Drug Design & Discovery · Vol. 7, Issue 2, 2020 · pp. 1–7 Read article →
-
Published Subscription
Impact of Clinical Pharmacist in Evaluating Drug–Drug Interactions in Outpatients of a Tertiary Care Hospital: An Observational StudyBy SUSHMA MUCHUKOTA, Gavini Siva Bharat, E. Bhavya, Babu Muchukota, Jai Divya Tella
Abstract: Background: In patients receiving multi-drug therapy, drug–drug interactions (DDIs) are of extensive concern. The term drug–drug interaction is used when the effect of one drug is altered by the concomitant use of another drug. Aim: To analyze the impact of clinical pharmacist in evaluating drug–drug interactions in outpatients of a tertiary care hospital in various departments in a tertiary care hospital. Objectives: To assess the prevalence of drug–drug interactions and …
Published in Trends in Drug Delivery · Vol. 7, Issue 1, 2020 · pp. 10–16 Read article →